Home Cart Sign in  
Chemical Structure| 1373215-15-6 Chemical Structure| 1373215-15-6

Structure of LY 3000328
CAS No.: 1373215-15-6

Chemical Structure| 1373215-15-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LY 3000328 is a highly selective and potent Cathepsin S inhibitor with IC50 of 7.7±5.85 nM and 1.67±1.17 nM for hCat S and mCat S respectively, can be used in treatment for abdominal aortic aneurysm.

Synonyms: Z-FL-COCHO; Compound 5

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of LY 3000328

CAS No. :1373215-15-6
Formula : C25H29FN4O5
M.W : 484.52
SMILES Code : O=C(C1=CC=C(F)C=C1)N[C@@H]2[C@@H](OC(NC)=O)COC3=CC=C(N4CCN(C5COC5)CC4)C=C32
Synonyms :
Z-FL-COCHO; Compound 5
MDL No. :MFCD28502827
InChI Key :NDEBZCZEAVMSQF-GOTSBHOMSA-N
Pubchem ID :67475270

Safety of LY 3000328

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of LY 3000328

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human corneal epithelial cells (HCECs) 50μM 48 h Prevented CTSS-induced loss of tight junction proteins ZO-1 and occludin PMC8908478

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice APP/PS1 transgenic mice Hippocampal stereotactic injection 0.2 mg/kg 5 consecutive days, once daily LY3000328 significantly alleviated the neuroinflammatory response, decreased Aβ deposition, and rescued learning and memory deficits in APP/PS1 mice via the CX3CL1-CX3CR1 axis and JAK2-STAT3 pathway PMC11822647
BALB/c mice TDI or OVA/CFA-induced mixed granulocytic asthma model Intraperitoneal injection 30 mg/kg Administered 30 minutes after each challenge, for a total of 3 times LY3000328 significantly alleviated airway hyperresponsiveness and neutrophilic inflammation induced by TDI or OVA/CFA, but had no effect on eosinophils and levels of IL-4 and IL-5 PMC11669210
Mouse CaCl2-induced AAA model Oral 1, 3, 10, 30 mg/kg Twice daily for 28 days Evaluate the effect of LY3000328 on aortic diameter in AAA model, showing dose-dependent reduction in aortic diameter PMC4190634
Sprague Dawley (SD) rats IBS-like rat model Intrathecal injection 1, 3, and 10 μg Once daily for 3 consecutive days LY3000328 dose-dependently down-regulated EMG amplitude and FKN expression, indicating that Cat S regulated visceral hypersensitivity via activating FKN in IBS-like rats. PMC10291865

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.06mL

0.41mL

0.21mL

10.32mL

2.06mL

1.03mL

20.64mL

4.13mL

2.06mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories